https://biotechmorning.com/news/first-drug-cerebral-adrenoleukodystrophy-nezglyal Biotech Morning en 2026-09-25T14:14:59.089Z The First Drug for a Disease That Had Zero https://biotechmorning.com/news/adarx-half-billion-dollar-ipo-bet-silencing-genes Biotech Morning en 2026-09-25T14:14:16.835Z A Half-Billion-Dollar Bet on Silencing Genes https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-picks-shovels-biotech Biotech Morning en 2026-09-25T14:13:33.673Z Merck KGaA Just Made a $11.3 Billion Bet on the Picks and Shovels of Biotech https://biotechmorning.com/news/end-of-daily-insulin-shots-finally-here Biotech Morning en 2026-09-25T14:12:51.736Z The End of Daily Insulin Shots Is Finally Here https://biotechmorning.com/news/acadia-alzheimers-drug-phase-2-miss-phase-3-anyway Biotech Morning en 2026-09-25T14:12:09.821Z Acadia's Alzheimer's Drug Missed by a Hair. They're Going to Phase 3 Anyway. https://biotechmorning.com/news/biogen-fda-breakthrough-designation-crl-sma Biotech Morning en 2026-09-25T14:11:21.571Z Biogen's Wild Day: An FDA Gold Star and a Rejection Letter, Both for SMA https://biotechmorning.com/news/genentech-earendil-bispecific-antibody-deal Biotech Morning en 2026-09-25T14:10:33.929Z Genentech Just Paid $55M for a Ticket Worth $1.5 Billion https://biotechmorning.com/news/one-shot-cholesterol-epigenetic-pcsk9-silencing Biotech Morning en 2026-09-25T14:09:47.093Z One Shot to Kill Your Cholesterol. Forever. https://biotechmorning.com/news/merck-belzutifan-lenvatinib-kidney-cancer-fda-approval Biotech Morning en 2026-09-25T14:08:57.956Z Merck Just Found Kidney Cancer's Double Lock (and the Two Keys to Open It) https://biotechmorning.com/news/carvykti-five-year-remission-multiple-myeloma Biotech Morning en 2026-09-25T14:08:13.673Z One Shot. Five Years. Half of These Cancer Patients Are Still in Remission. https://biotechmorning.com/news/lilly-100m-innocare-beijing-deal Biotech Morning en 2026-09-24T14:20:23.640Z Lilly's $100M Bet on a Beijing Biotech Isn't Supposed to Happen Right Now https://biotechmorning.com/news/europe-pharma-ceos-sos-biotech-decline Biotech Morning en 2026-09-24T14:19:41.622Z Europe's Biggest Pharma Companies Just Sent an SOS https://biotechmorning.com/news/sefaxersen-igan-phase-3-crowded-market Biotech Morning en 2026-09-24T14:18:59.875Z The Kidney Drug That Just Crashed Biotech's Most Crowded Party https://biotechmorning.com/news/roche-2-billion-atavistik-bio-cvrm-deal Biotech Morning en 2026-09-24T14:18:13.450Z Roche Just Bet $2 Billion on a Company Most People Haven't Heard Of https://biotechmorning.com/news/merck-remigromig-brunello-trial-dme Biotech Morning en 2026-09-24T14:17:24.399Z Merck Just Found a Way to Fix Leaky Blood Vessels in the Eye https://biotechmorning.com/news/galleri-blood-test-fda-panel-vote Biotech Morning en 2026-09-24T14:16:40.024Z A Blood Test That Catches 50+ Cancers Just Cleared Its Biggest Hurdle https://biotechmorning.com/news/eu-gene-edited-crops-regulation-shift Biotech Morning en 2026-09-24T14:15:53.766Z Europe Just Cracked Open the Door to Gene-Edited Crops https://biotechmorning.com/news/flagship-pioneering-pentagon-biodefense-contract Biotech Morning en 2026-09-24T14:15:12.133Z Flagship Pioneering Just Became a Defense Contractor https://biotechmorning.com/news/enveda-311m-series-e-plant-ai-drug-discovery Biotech Morning en 2026-09-24T14:14:29.658Z The $311M Bet That Plants Are Smarter Than Pharma Chemists https://biotechmorning.com/news/kyverna-car-t-miv-cel-autoimmune-one-year-data Biotech Morning en 2026-09-24T14:13:40.399Z Kyverna's CAR-T Therapy Just Did Something Its Rivals Can't https://biotechmorning.com/news/fda-nominee-heidi-overton-senate-confirmation-hearing Biotech Morning en 2026-09-24T14:12:53.404Z The FDA's Next Boss Has Never Run Anything Like the FDA